Chapin Davis’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
Other funds holding BEAM
Chapin Davis's BEAM Position: Q3 2026 in Review
Chapin Davis sold out of Beam Therapeutics (BEAM) in Q3 2026, closing a stake of 6,000 shares — an estimated $206K sold.
Chapin Davis first reported a position in BEAM in Q2 2026 and held it in 1 quarter. The position peaked at $206K in Q2 2026. 191 funds tracked by Wall St. Rank hold BEAM as of Q3 2026.
- Chapin Davis reported no remaining Beam Therapeutics position as of Q3 2026 after selling out during the quarter.
- Chapin Davis sold 6,000 Beam Therapeutics shares in Q3 2026, an estimated $206K.
- Chapin Davis first reported a position in Beam Therapeutics in Q2 2026 and held it in 1 quarter.
- Chapin Davis's Beam Therapeutics position peaked at $206K in Q2 2026.
- 191 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2026.
Based on Chapin Davis's 13F filing for Q3 2026, filed 9 Oct 2026.